|

METABolic Deterioration in HTX Determines Outcomes

RECRUITINGSponsored by Heinrich-Heine University, Duesseldorf
Actively Recruiting
SponsorHeinrich-Heine University, Duesseldorf
Started2025-07-24
Est. completion2030-04-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07372820

Summary

METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age: ≥ 18 years
* Planned or already conducted heart transplantation
* Informed consent

Exclusion Criteria:

* Absence of informed consent

Conditions3

DiabetesHeart DiseaseHeart Transplantation

Browse More Trials

Heart Disease trialsDiabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.